NEW YORK (GenomeWeb) – Mitra BiotechRxDx, which does business in the US as Mitra Biotech, said it has completed a $40 million financing round, bringing the total amount it has raised to date to $76 million.

The latest funding round was led by Northpond Ventures, and included existing investors Accel Partners, Sequoia India, Sands Capital Ventures, and RA Capital Management.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Sometimes genetic tests give inconclusive results and provide little reassurance to patients, the Associated Press reports.

Vox wonders whether gene-editing crops will be viewed similarly as genetically modified organisms of if people will give them a try.

In Science this week: research regulation and reporting requirement reform, and more.

With H3Africa, Charles Rotimi has been working to bolster the representation of African participants and African researchers in genomics, Newsweek reports.